Our Services & Solutions

We offer all services and analytics required to evaluate life science assets.

Fund Raising

Investment Decisions shall be driven by thorough analyses that integrate

  • all commercial aspects including a drug’s current and future competitive environment as well as pharmacoeconomics (also see > Commercial Assessment),
  • the analysis and mitigation of development risk (also see > R&D Productivity Increase),
  • the identification of a company’s cost of capital,
  • the calculation of expected (‘risk-adjusted’) net present values (‘eNPVs’),
  • the assessment how value is expected to increase once defined milestones have been reached,
  • ‘comparables’, i.e. market transactions with a known value.

Bioscience Valuation supports management with comprehensive analyses and clear investment recommendations that can be shared with any stakeholder.